The 2018 British Isles and Rest of the Traveller, Professor TT Cheung, has just returned from his travels. Professor Cheung visited our colleagues at King’s College, Heidelberg University Hospital and the Royal Infirmary of Edinburgh. To view some highlights from his trips, please click HERE.
Thank you to all our terrific hosts and to the BJS Society for supporting the Association, allowing us to fund fellowship opportunities.
Dr. Jason Sicklick is an NIH-funded investigator and Associate Professor of Surgery at the UC San Diego Moores Cancer Center. He is a board-certified general surgeon and surgical oncologist specializing in the treatment of hepatobiliary diseases and sarcomas, including gastrointestinal stromal tumors (GIST). In 2016, Dr. Sicklick was named the GIST Clinician of the Year by the Life Raft GIST Support Group, the largest GIST patient advocacy group in the world.
He received his medical degree from the UCLA School of Medicine, completed his general surgery residency at The Johns Hopkins Hospital where he was the Administrative Chief Resident, and completed a fellowship in surgical oncology at Memorial Sloan Kettering Cancer Center where he was the Chief Administrative Fellow. He joined the Division of Surgical Oncology at Moores Cancer Center in 2010. Dr. Sicklick is an active member of the National Cancer Institute’s GIST Working Group, the National Comprehensive Cancer Network (NCCN) Hepatobiliary Committee, and the Transatlantic Atlantic Retroperitoneal Sarcoma Working Group. Dr. Sicklick is on the Editorial Board of Annals of Surgical Oncology, Journal of Gastrointestinal Surgery and Journal of Surgical Research. He has published in prestigious journals such as Nature, Gastroenterology, Cancer Research, Annals of Surgery, Archives of Surgery, and Annals of Surgical Oncology. He is a member of the numerous societies including the American College of Surgeons, the Society for University Surgeons, the Association of Academic Surgery, the Society of Surgical Oncology, American Society of Clinical Oncology, American Association for Cancer Research, and Connective Tissue Oncology Society. His translational and clinical research focus on molecular mechanisms of GIST and hepatocellular carcinoma, as well as precision medicine approaches to cancer therapy.
Justin B. Dimick, M.D., M.P.H. is the George D. Zuidema Professor of Surgery, Chief of the Division of Minimally Invasive Surgery, and Associate Chair for Strategy & Finance at the University of Michigan. Dr. Dimick is a graduate of Cornell University and Johns Hopkins Medical School. He completed his surgical training at the University of Michigan and a health services research fellowship at the Dartmouth Institute for Health Policy & Clinical Practice.
Dr. Dimick has served in several national leadership positions, including President of the Association for Academic Surgery (AAS) and a Member of the Board of Directors for the Surgical Outcomes Club (SOC). He is currently Chair of the Health Services Organization and Delivery (HSOD) Study Section at the NIH, an Associate Editor at Annals of Surgery, and the Surgical Innovation Editor at JAMA Surgery. He has served as an advisor on quality and health policy for several organizations, including the BlueCross BlueShield Association (BCBSA), the American College of Surgeons-National Surgical Quality Improvement Program (ACS-NSQIP), US News and World Reports “Best Hospital” Rankings, and the Medicare Payment Advisory Commission (MedPAC).
Dr. Dimick’s clinical practice is primarily devoted to advanced laparoscopy, including treatment of morbid obesity, gastroesophageal reflux (GERD), paraesophageal hernias, abdominal wall hernias, and other benign and neoplastic diseases of the stomach, spleen, and foregut. He is the editor of the widely read surgical textbook, Clinical Scenarios in Surgery: Decision Making and Operative Technique, published by Lippincott (2012).
A graduate of the University of Toronto Medical School in 1996, Dr. Wright entered the General Surgery Training Program at Queen’s University, Kingston in 1996. She became a Fellow of the Royal College of Physicians and Surgeons of Canada in 2001. She completed a Surgical Oncology Fellowship at the University of Toronto in 2003. After completing a Masters in Education at OISE at the University of Toronto in 2004 which focused on continuing medical education or knowledge translation, she began her general surgery staff appointment at Sunnybrook Health Sciences Centre in 2004. She is currently an Associate Professor in the Department of Surgery at The University of Toronto. Her clinical practice is devoted to breast cancer and melanoma. She is currently consulting for Cancer Care Ontario concerning multidisciplinary cancer conferences and their provincial implementation. Her research interests are knowledge translation.
Dr. Wright is involved in knowledge translation and getting best evidence into practice, particularly in the area of cancer surgery. She is doing work on implementing multidisciplinary cancer conferences in Ontario. Clinical research revolves around choices women make with breast cancer surgery and outcomes for patients with melanoma. Her area of methodological expertise is qualitative research.
Dr. Wright is involved in knowledge translation and getting best evidence into practice, particularly in the area of cancer surgery. She is doing work on implementing multidisciplinary cancer conferences in Ontario. Clinical research revolves around choices women make with breast cancer surgery and outcomes for patients with melanoma. Her area of methodological expertise is qualitative research.
Tan To Cheung, MBBS, MS, FRCS(Ed), FCSHK, FHKAM, is the Chief of the Division of Hepatobiliary and Pancreatic Surgery within the Department of Surgery, Queen Mary Hospital, the University of Hong Kong and the Council member of the Hong Kong Society of Hepatobiliary and Pancreatic Surgery. He is also Associate Professor of Surgery at the University of Hong Kong.
Dr. Cheung received his medical degree in the University of Hong Kong. After graduating, Dr. Cheung started his career as Surgeon in Queen Mary Hospital and with his interest in complicated liver surgery and liver transplantation he became a staff member in Division of Hepatobiliary and Pancreatic Surgery Since 2006.
Dr. Cheung is one of the leading experts in laparoscopic liver resection in Hong Kong. He has performed more than 300 pure laparoscopic liver hepatectomy in Hong Kong. He published the results of laparoscopic hepatectomy in Queen Mary Hospital in various journal including Annals of Surgery and World Journal of Surgery.
He is keen on new procedures development and he is an active researcher in the field of liver transplant, complicated liver surgery, ALPPS procedures, minimally invasive surgery for liver cancer and the role of dual tracer PET CT on diagnosis of HCC. Dr. Cheung has obtained his post graduate doctoral degree (Master of Surgery HKU) on the research of treatment of HCC in liver cirrhosis. He is the world leading expert in the area of high intensity focused ultrasound (HIFU) therapy for HCC. He performed the first HIFU therapy for patients waiting for liver transplant in the world.
Dr. Cheung is the recipient of the GB Ong travelling Fellowship Award. He has won many other wards including travelling awards, Best Oral Presentation awards, Best Video awards, Best Poster awards in various international meetings. He has authored more than 130 peer-reviewed articles and other publications, is frequently invited to lecture internationally including presentations in plenary sessions, and has mentored a large number of trainees.